In December, PersonGen was included in the list of  " 2023 Deloitte China Life Sciences & Healthcare (LSHC) Rising Star ".

In December, PersonGen.Anke Cellular Therapeutics Co., Ltd.won the honorary title of " Gazelle Cultivation Enterprise " and " Advanced Technology Enterprise " in Hefei High-tech Zone in 2023.

In December, PersonGen was awarded the key project for technology development of the " 2023 National Biological Medicine Technology Innovation Center ".

In November, PersonGen.Anke Cellular Therapeutics Co., Ltd. joined Anhui Pharmaceutical Industry Association.

In November, PersonGen.Anke Cellular Therapeutics Co., Ltd. was granted the " 2023 Hefei Enterprise Technology Center ".

In October, PersonGen won the  " Winning Project Award "  in the  2nd Yangtze River Delta G60 Science and Innovation Corridor Technology and Industry Innovation Competition".

In October, Dr. Wang Min, Vice President of PersonGen.Anke, joined the Hefei High-tech Zone Women Entrepreneurs Association.

In September, PersonGen BioTherapeutics (Suzhou) Co., Ltd. was approved as the first batch of nursery enterprises in 2023.

In September, PersonGen.Anke Cellular Therapeutics Co., Ltd. won the " 2023 Pharmaceutical Company Digital Intelligence Transformation Intelligent Production Leadership Award ".

In August, Dr. Wang Min, Vice president of PersonGen.Anke, won the 2023 BPD " Young Craftsman Award of Biological Medicine ".

In July, Dr. Wang Min, Vice President of PersonGen, was selected as one of the U40-Young Elites.

In June, Dr. Lin Yang, founder of PersonGen, won the " BioCon Awards - the Influence Star of Biotech Industry in 2023 ".

In April,  the B7-H3 CAR T cell therapy product " TAA06 injection " for the treatment of relapsed/refractory neuroblastoma completed the first patient dosing.

In April, PersonGen BioTherapeutics (Suzhou) Co., Ltd. won the " CGT Industry Star - 2023 Most Innovative Award ".

In March, the opening ceremony of the intelligent and fully-automated cell production base of PersonGen and the "PersonGen Cell Therapy Development Innovation Summit " were grandly held in Hefei on March 28th,2023.

In March,  PersonGen.Anke Cellular Therapeutics Co., Ltd. won the " Winning Project Award " in the finals of the " 2022 National Disruptive Technology Innovation Competition ".

In March, PersonGen BioTherapeutics (Suzhou) Co., Ltd. won the " Excellent Project Award " in the finals of the " 2022 National Disruptive Technology Innovation Competition ".

In March, PersonGen.Anke Cellular Therapeutics Co., Ltd. won the " Excellence award " in the final of " The 3rd Yangtze River Delta Translational Medicine (medical device direction) Innovation and Entrepreneurship Competition ".

In March, PersonGen BioTherapeutics (Suzhou) Co., Ltd. was awarded  " 2022 TOP 100 Innovative Breakthrough Enterprises ".

In February, PersonGen.Anke Cellular Therapeutics Co., Ltd. became one of the governing unit of Hefei Biomedical Industry Association.